The latest report that belimumab, a human monoclonal antibody targeting BAFF (B-cell activating factor, also known as TNF ligand superfamily member 13B or BLyS), was not better than placebo in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results